Stephan Gade
Heidelberg, BW 69117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo.
Journal: Journal of medicinal chemistry
Published: June 22, 2026
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation.
Journal: Cancer research communications
Published: January 17, 2024
Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition.
Journal: Molecular systems biology
Published: January 17, 2024
Proteomic signatures improve risk prediction for common and rare diseases.
Journal: Nature medicine
Published: October 26, 2023
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis.
Journal: Cell
Published: June 11, 2017
Monitoring Cell-surface N-Glycoproteome Dynamics by Quantitative Proteomics Reveals Mechanistic Insights into Macrophage Differentiation.
Journal: Molecular & cellular proteomics : MCP
Published: September 09, 2016
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry.
Journal: Nature protocols
Published: September 18, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
Journal: Breast cancer research and treatment
Published: January 23, 2015
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 24, 2014
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2014
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
Journal: Breast cancer research and treatment
Published: June 27, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data.
Journal: Genome biology
Published: May 02, 2014
Last Updated: 09/26/2026